SYNPLOID BIOTEK LLC has a total of 20 patent applications. It decreased the IP activity by 57.0%. Its first patent ever was published in 2017. It filed its patents most often in Canada, EPO (European Patent Office) and United States. Its main competitors in its focus markets biotechnology, foods and drinks and pharmaceuticals are ALGENTECH SAS, SHENZHEN NONGKE GROUP CO LTD and MODALIS THERAPEUTICS CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 5 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | United States | 5 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | China | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Foods and drinks | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Measuring microorganism processes | |
#4 | Enzymes | |
#5 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Perkins Edward | 20 |
#2 | Greene Amy | 20 |
#3 | Broccoli Dominique | 6 |
Publication | Filing date | Title |
---|---|---|
WO2019050875A1 | Lineage reporter synthetic chromosomes and methods of use | |
US2020131530A1 | Compositions and Methods of Chromosomal Silencing | |
EP3555261A1 | Methods of cell renewal | |
US2020157553A1 | Sequential loadings of multiple delivery vectors using a single selectable marker | |
EP3443084A2 | Methods for creating synthetic chromosomes having gene regulatory systems and uses thereof | |
CN109328232A | For generating the method and application thereof of the synthesis chromosome of expression biosynthesis pathway |